ABSTRACT
Amiodarone 387 Beta-blockers 387 Angiotensin-converting enzyme
inhibitors 387 Diltiazem 388 Minoxidil 388
Ergot derivatives 388 Tyrosine kinase inhibitors 388
Dasatinib, imatinib, and nilotinib 388 Erlotinib 388
Biologic agents 389 Interleukin-2 389 Interleukin-11 389 Sirolimus 389 Bortezomib 389 Immunoglobulin 389 Granulocyte-Colony-Stimulating Factor (G-CSF) 389
Chemotherapy agents 389 Bleomycin 389 Methotrexate 389 Cyclophosphamide 389 Other chemotherapeutics389 Anticoagulants and thrombolytics 390
Sclerotherapy 390 Miscellaneous drugs 390
Acyclovir 390 Clozapine 390 Fluoxetine 390 Glitazones 390 Insulin 390 Itraconazole 390 L-Tryptophan 390 Mesalamine 391 Statins 391 Tizanidine 391
Drug-induced lupus pleuritis 391 Procainamide 391 Hydralazine 391 Isoniazid 391 Quinidine 391 D-Penicillamine 391 Anti-TNF agents 392
Drug-induced eosinophilic pleural effusion 392 Nitrofurantoin 392 Valproic acid 392 Dantrolene 392 Isotretinoin 392 Propylthiouracil 392 Gliclazide 392
Ovarian hyperstimulation syndrome (OHS) 393 Conclusion 393 References 393
● Drug-induced pleural eusion may occur as an isolated disorder, accompany parenchymal disease, or appear in the context of systemic reactions.
